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Abstract
Background: The objective was to determine the influence of gestational age, maternal, and neonatal variables on
reference intervals for cord blood bone minerals (calcium, phosphate, magnesium) and related laboratory tests
(alkaline phosphatase, and albumin-adjusted calcium), and to develop gestational age specific reference intervals
based on infants without influential pathological conditions.
Methods: Cross-sectional study. 702 babies were identified as candidates for this study in a regional referral
neonatal unit. After exclusions (for anomalies, asphyxia, maternal magnesium sulfate administration, and death),
relationships were examined between cord blood serum laboratory analytes (calcium, phosphate, magnesium,
alkaline phosphatase, and albumin-adjusted calcium) with gestation age and also with maternal and neonatal
variables using multiple linear regression. Infants with influential pathological conditions were omitted from the
development of gestational age specific reference intervals for the following categories: 23-27, 28-31, 32-34, 35-36
and > 36 weeks.
Results: Among the 506 preterm and 54 terms infants included in the sample. Phosphate, magnesium, and alkaline
phosphatase in cord blood serum decreased with gestational age, calcium increased with gestational age. Those who
were triplets, small for gestational age, and those whose mother had pregnancy-induced hypertension were influential
for most of the analytes. The reference ranges for the preterm infants ≥ 36 weeks were: phosphate 1.5 to 2.6 mmol/L
(4.5 to 8.0 mg/dL), calcium: 2.1 to 3.1 mmol/L (8.3 to 12.4 mg/dL); albumin-adjusted calcium: 2.3 to 3.2 mmol/L (9.1 to
12.9 mg/dL); magnesium 0.6 to 1.0 mmol/L (1.4 to 2.3 mg/dL), and alkaline phosphatase 60 to 301 units/L.
Conclusions: These data suggest that gestational age, as well as potentially pathogenic maternal and neonatal
variables should be considered in the development of reference intervals for preterm infants.
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Background
In addition to the structural roles calcium, phosphate,
and magnesium have in bone, these minerals also have
key roles in most cellular, physiological and biochemical
processes. Pediatric Societies recommend that preterm
infants grow similar to the fetus [1-3], and maintain fetal
concentrations in blood and tissues [1,2]. Experts on
bone mineralization of preterm infants recommend that
cord blood serum phosphate be maintained greater than
1.5 mmol/L (4.5 mg/dl) [4], 1.8 mmol/L (5.6 mg/dl) [5],
or 1.9 mmol/L (5.8 mg/dL) [6], and alkaline phosphatase
(ALP) be less than 400 [5] or 800 units/L [4]. To our
knowledge only small studies have documented bone
minerals related analytes (calcium, phosphate, magne-
sium, alkaline phosphatase, and albumin-adjusted cal-
cium,) in cord blood serum of preterm infants [7-9] or
fetal blood [10-13]. None of these studies have systemati-
cally evaluated the effect of potentially influential mater-
nal and infant medical conditions on cord blood serum
bone minerals (calcium, phosphate, magnesium) and
related laboratory tests (ALP and albumin-adjusted
calcium).
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cord blood serum levels of bone minerals (cord blood
serum calcium, phosphate, and magnesium), and related
laboratory tests (ALP and albumin-adjusted calcium)
vary with a) gestational age and/or b) maternal and/or
neonatal variables, and to 2) estimate the cord blood
serum reference intervals for healthy preterm infants
born between 23 and 36 weeks of gestational age, that is,
preterm infants who were not influenced by potentially
pathogenic maternal or neonatal variables.
Methods
This cross-sectional study was approved by the Conjoint
Health Research Ethics Board, University of Calgary and
Calgary Health Region, and conducted in Foothills Hos-
pital, the regional high-risk maternal and neonatal refer-
ral centre for Southern Alberta between July 2003 and
February 2005. Umbilical cord blood of the subjects was
identified among samples routinely banked at delivery for
all births (n = 7174). Candidate preterm infants (< 36-37
weeks) were identified from the admission lists to the
n e o n a t a li n t e n s i v ec a r eu n i t .C a n d i d a t es i n g l e t o nt e r m
infants were randomly selected from the list of cord
blood samples in July, September and January using ran-
dom number lists. The serum was stored at -70 C prior
to testing.
Informed consent was requested from the parents by tel-
ephone to analyze the blood sample and review the
infant’s chart for gestational age, and co-morbidities.
Gestational age, measured in weeks completed, was based
on primarily on maternal dates and early ultrasounds or
the modified Ballard score [14] assessment. Size for gesta-
tional age was assigned using the 10
th and 90
th centiles
using reference values [15].
702 infants, 634 preterm and 68 term infants were iden-
tified as candidates for this study. The parents of 28
infants refused inclusion of their babies (23 preterm (3.6%)
and 5 term (7.6%)) in the study, and 63 parents were not
able to be contacted in four attempts (54 preterm (8.3%)
and 9 term (13.6%)). Infants were excluded from the
study: 17 babies for asphyxia (2
nd Apgar ≥ 3 or cord pH <
7.0) [16], 13 (1.8%) for magnesium-sulfate treatment dur-
ing labour [17], seven (1.0%) for anomalies, and 14 (2.0%)
who died prior to hospital discharge.
Cord blood serum calcium, phosphate, magnesium and
ALP (total ALP = from bone and liver) were determined
on a Hitachi 917 (Roche Diagnostics Canada, Laval)
using the manufacturers reagents and calibrators. Albu-
min-adjusted calcium was calculated using the bromocre-
sol purple albumin binding reagent equation adjusted
[calcium](mmol/L) = total [calcium](mmol/L) + 0.012
(39.9 - [albumin](g/L)[18]) since these values are useful
to consider for subjects with hypoalbuminemia.
Statistical Methods
The distributions of categorical variables observed were
summarized as percentages by gestational age group
(Table 1). Subsequently, for each analyte, a simple linear
regression analysis was used to examine the relationship
between the analyte (dependent variable) and gestational
age in completed weeks (independent variable). In all
regression models the intragroup correlation induced by
twins and triplets was accounted for using a robust var-
iance estimator for cluster correlated data [19], implemen-
ted using the cluster option in the regress command in
Stata 11.
A quadratic variable for gestational age was fitted to
examine whether there was evidence of a non linear com-
ponent. Subsequently, each of the potentially influential
variables (maternal diabetes (none, pre-existing or gesta-
tional), multiple births (twin and/or triplet), pregnancy-
induced hypertension (PIH), beta-methasone use, small
for gestational age (SGA), gender, birth season (summer
versus winter as a surrogate measure of vitamin D status)
[20], delivery (caesarean vs. vaginal), and arterial pH) were
added to gestational age one at a time in a multiple linear
regression model (adjusting for correlated data as above)
to assess for confounding and to determine whether these
variables were statistically significant predictors of the ana-
lyte. Each variable was considered a confounding variable
of the relationship between gestational age and the analyte
if it changed the estimate of the slope between the analysts
and gestational age by more than 10% when included in
the model, or was considered a statistically significant pre-
dictor of the analyte after controlling for gestational age (if
the p -value for the Wald statistic was < 0.05). Subse-
quently all potential confounding and significant variables
were included in a multivariable model (i.e. multiple linear
regression model) but removed if p > 0.05 or if no evi-
dence of confounding by that variable. To assess the clini-
cal relevance of a significant predictor variable in terms of
the construction of the reference intervals, the magnitude
of each coefficient was reported as a percent of the overall
mean and standard deviation for that analyte.
There was apparent evidence of some confounding of
the relationship between each analyte and gestational age
by pH but this was found to be due to missing pH values
(6%). Thus a variable was used to categorize the non-miss-
ing and missing blood pH into 3 categories (< or > 7.35 vs.
missing), to allow examination of the effect of the missing
data so that all the data could be used in the regression
analysis.
For the generation of the reference intervals, when
potentially pathogenic conditions were found to substan-
tially affect the levels of the analyte, the individual babies
with these conditions were omitted for that analyte.
Potentially pathogenic conditions were defined ap r i o r i
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influenced the analyte, and whose influence, singly or
combined, was greater than 10% of the mean or greater
than 50% of the standard deviation. Reference intervals
were calculated using the mean ± 1.96 standard devia-
tions within strata defined by gestational age groups of
23-27, 28-31, 32-34, 35-36 and > 36 weeks.
Results
The study sample included 506 preterm and 54 term
infants. The majority of infants were 32 to 36 weeks of
gestational age, but ranged from 23 to 42 weeks (Table 1).
Most of the mothers and infants did not have any medical
conditions, most were singleton births (65%), 4.8% were
SGA, 52% were given at least one dose of beta-methasone,
and 53% had caesarean births. The reference intervals for
the various gestational age categories are shown in Table 2
(mmol/L) and Table 3 (mg/dl).
Phosphate
Serum phosphate was negatively related to gestational
age (Table 4). No variables confounded the relationship
between cord blood serum phosphate and gestational
age, but three variables were significant predictors of
cord blood serum phosphate: triplets, SGA, and PIH.
These three variables were entered into the multivariable
regression model; triplets and PIH remained significant
in the multivariable model (Table 4). The effect of both
t r i p l e t sa n dP I Hd e c r e a s e dt h ec o r db l o o ds e r u mp h o s -
phate level, and triplets surpassed the preset change rela-
tive to the standard deviation (Table 4), so the 22 triplets
(3.9%) were omitted for the development of the reference
intervals.
Calcium
Serum calcium was positively related to gestational age
(Table 4). On individual analysis for calcium, four variables
were predictive of calcium in addition to gestational age:
multiple births, delivery, SGA, and maternal PIH; no vari-
ables confounded the association with gestational age. The
variables indicating multiple births and method of delivery
were highly correlated since multiple births were more
likely to be delivered by caesarean than singleton births, so
these two variables could not be included in the multivari-
able model simultaneously. We chose to enter multiple
births rather than delivery since it made more sense
Table 1 Subject characteristics
Gestational Age (weeks) 23-27 28-31 32-34 35-36 All preterrm Term
n %n%n%n% n %n%
n 51 9% 133 24% 199 36% 123 22% 506 90% 54 10%
Male 26 51% 83 62% 103 52% 74 60% 286 57% 34 63%
Female 25 49% 50 38% 96 48% 49 40% 220 43% 20 37%
Diabetes
None 50 98% 113 85% 187 94% 114 93% 464 92% 52 96%
Pre-existing 1 2% 8 6% 6 3% 3 2% 18 4% 1 2%
Gestational 0 0% 12 9% 6 3% 6 5% 24 5% 1 2%
Multiple Births
Single 39 76% 81 61% 115 58% 76 62% 311 61% 54 100%
Twin 12 24% 41 31% 77 39% 43 35% 173 34% 0 0%
Triplet 0 0% 11 8% 7 4% 4 3% 22 4% 0 0%
Winter 27 53% 59 44% 114 57% 62 50% 262 52% 22 41%
PIH 1 2% 22 17% 31 16% 14 11% 68 13% 1 2%
SGA 49 96% 130 98% 192 96% 108 88% 27 95% 54 100%
Beta-methasone 41 80% 114 86% 113 57% 19 15% 287 57% 0 0%
Delivery
Vaginal 24 47% 51 38% 97 49% 52 42% 224 44% 38 72%
Caesarean 27 53% 82 62% 101 51% 71 58% 281 56% 15 28%
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maternal PIH were statistically significant predictors in the
multivariable model (Table 4) after adjusting for gesta-
tional age. Although these three variables were statistically
significant predictors of decreased calcium levels, none of
them individually surpassed indicators of influence unless
infants had two of the three conditions: triplets, SGA, and
being from a pregnancy with PIH (Table 4). Two of the
three conditions occurred among only 48 babies (8.6%),
and these infants were omitted for the development of the
reference intervals.
Albumin-adjusted Calcium
Total cord blood serum calcium was positively related to
cord blood serum albumin, and albumin-adjusted cord
blood serum calcium was related to gestational age (Table
4). On individual analysis for albumin-adjusted calcium
with gestational age, four variables were predictive: multi-
ple births, maternal PIH, SGA, and delivery; no variables
confounded the association with gestational age. Multiple
births were no longer predictive in the multivariable
model (Table 4). The conditions of caesarean delivery,
maternal PIH and SGA exceeded the preset criteria for
influence when infants had at least two of the three condi-
tions (Table 4), which occurred among 64 infants (11.4%),
and they were omitted from the reference ranges.
Magnesium
Serum magnesium was negatively related to gestational
age (Table 4). Multiple birth (twins and triplets), and
beta-methasone use were confounding factors for gesta-
tional age, and multiple births was also significant pre-
dictor of lower cord blood serum magnesium levels.
However, beta-methasone use was no longer predictive
Table 2 Laboratory Reference Intervals by gestational age for phosphate, calcium, albumin-adjusted calcium,
magnesium (mmol/L), and alkaline phosphatase (units/L)
Phosphate (mmol/L)
Gestational Age (weeks) n Mean SD Lower limit* Upper Limit*
23-27 51 2.1 0.3 1.6 2.6
28-31 119 2.0 0.3 1.4 2.7
32-34 191 2.0 0.2 1.5 2.5
35-36 119 2.0 0.3 1.4 2.6
> 36 weeks (term) 52 1.8 0.2 1.4 2.3
Calcium (mmol/L)
23-27 51 2.5 0.2 2.0 3.0
28-31 115 2.6 0.3 2.0 3.1
32-34 176 2.6 0.2 2.2 3.1
35-36 110 2.6 0.3 2.1 3.1
> 36 weeks (term) 52 2.7 0.1 2.5 3.0
Albumin-adjusted Calcium (mmol/L)
23-27 49 2.7 0.2 2.2 3.2
28-31 109 2.7 0.3 2.2 3.3
32-34 175 2.8 0.2 2.3 3.2
35-36 116 2.7 0.2 2.3 3.2
> 36 weeks (term) 51 2.8 0.1 2.6 3.0
Magnesium (mmol/L)
23-27 48 0.79 0.07 0.65 0.94
28-31 127 0.79 0.10 0.58 0.99
32-34 193 0.76 0.08 0.60 0.92
35-36 120 0.76 0.09 0.58 0.93
> 36 weeks (term) 53 0.77 0.08 0.63 0.92
Alkaline Phosphatase (units/L)
23-27 50 201 61 80 321
28-31 130 196 68 61 330
32-34 197 174 55 66 283
35-36 123 166 56 57 275
> 36 weeks (term) 52 159 49 62 256
* Lower limit is the mean - 1.96 SD and the upper limit is the mean + 1.96 SD.
Infants were omitted from the development of the reference intervals when they had pathogenic conditions that were found to be influential to the results,
based on a priori established criteria.
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gestion of a quadratic relationship between gestational
age and cord blood serum magnesium this was not in
evidence in the multivariable analysis. Although multiple
birth infants had significantly lower cord blood magne-
sium, it did not surpass the preset change of the mean
or standard deviation (Table 4), so no infants were
omitted from the reference intervals.
Alkaline phosphatise
ALP was negatively related to gestational age (Table 4).
On individual analysis for ALP, no variables were pre-
dictive of ALP or confounded the association with gesta-
tional age.
Gender, maternal diabetes, and birth season were not
significant predictors nor confounders for any of the
analytes.
Discussion
Serum phosphate, calcium, magnesium and ALP varied
with gestational age, cord blood serum phosphate, magne-
sium and ALP negatively and calcium positively. The exis-
tence of these relationships between cord blood bone
minerals levels (serum calcium, phosphate, and magne-
sium), and related laboratory tests (ALP, and albumin-
adjusted calcium), with gestational age, and other neonatal
variables (multiple birth, maternal PIH, and small size for
gestational age) suggests that these factors should be con-
sidered for the development of preterm reference intervals.
Our ranges of preterm cord blood phosphate and cal-
cium (Tables 2 and 3) are compatible with expert recom-
mendations [5,6]. In contras t ,o u rp r e t e r mc o r db l o o d
range of ALP are considerably lower than expert recom-
mendations to maintain preterm infant ALP less 400 [5]
or 800 units/L [4]. The cord blood ALP reference range
Table 3 Laboratory Reference Intervals by gestational age for phosphate, calcium, albumin-adjusted calcium,
magnesium (mg/dL), and alkaline phosphatase (units/L)
Phosphate (mg/dL)
Gestational Age (weeks) n Mean SD Lower limit* Upper Limit*
23-27 51 6.5 0.9 4.9 8.2
28-31 119 6.3 1.0 4.3 8.2
32-34 191 6.1 0.8 4.6 7.8
35-36 119 6.1 1.0 4.2 8.0
> 36 weeks (term) 52 5.7 0.7 4.3 7.1
Calcium (mg/dL)
23-27 51 10.0 1.0 8.1 11.9
28-31 115 10.2 1.2 8.0 12.5
32-34 176 10.5 1.0 8.6 12.4
35-36 110 10.4 1.1 8.3 12.5
> 36 weeks (term) 52 10.9 0.5 9.8 11.9
Albumin-adjusted Calcium (mg/dL)
23-27 49 10.8 0.9 8.9 12.6
28-31 109 10.9 1.1 8.8 12.9
32-34 175 11.1 0.9 9.3 12.7
35-36 116 10.9 0.9 9.0 12.8
> 36 weeks (term) 51 11.2 0.5 10.2 12.2
Magnesium (mg/dL)
23-27 48 1.9 0.2 1.6 2.3
28-31 127 1.9 0.3 1.4 2.4
32-34 193 1.8 0.2 1.5 2.2
35-36 120 1.8 0.2 1.4 2.3
> 36 weeks (term) 53 1.9 0.2 1.5 2.2
Alkaline Phosphatase (units/L)
23-27 50 201 61 80 321
28-31 130 196 68 61 330
32-34 197 174 55 66 283
35-36 123 166 56 57 275
> 36 weeks (term) 52 159 49 62 256
* Lower limit is the mean - 1.96 SD and the upper limit is the mean + 1.96 SD.
Infants were omitted from the development of the reference intervals when they had pathogenic conditions that were found to be influential to the results,
based on a priori established criteria.
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infant since the postnatal levels are considerably different
from the cord blood levels, and may not be achievable in
clinical care of preterm infants.
These results come from a single center, which could
be influenced by local events or lab methodology.
Therefore these results should be verified and validated
by larger multicentre studies.
Albumin-adjusted calcium values are useful to consider
for subjects with hypoalbuminemia, since non-adjusted
total calcium can be reduced by a lower albumin-bound
fraction, while the ionized physiologically active portion
may be normal. Therefore, when cord blood serum
ionized calcium is not available, or not appropriate, the
use of albumin-adjusted calcium is superior to the use of
total calcium in hypoalbuminemic patients. Measurement
of ionized calcium is altered by changes in cord blood
serum pH [21], and therefore its utility in cord blood is
hampered since pH can be variable in cord blood.
A l t h o u g hr e f e r e n c ei n t e r v a l sa r eu s e f u lt oc o n s i d e r
when evaluating the health status of any group, they may
or may not define ideal health status. Research is needed
to determine whether these reference ranges define the
ideal serum levels for preterm infants, or whether the
expert recommendations for cord blood serum phos-
phate (maintained greater than 1.8 mmol/L [5]), and/or
ALP (less than 400 [5] units/L may be superior goals
and/or more relevant. Reference intervals from cord
blood at preterm births are generated from infants who
are born prematurely, and for that reason may not be in
a state of ideal health. However, the fetus is considered to
be the reference source for the establishment of the goals
for normal concentrations of nutrients in the blood and
tissue [1,2] and cord blood provides a convenient oppor-
tunity to sample fetal blood.
Serum calcium is usually maintained within a limited
range in vivo by homeostatic mechanisms. It is interesting
that our preterm lower limits for calcium extended lower
than the term lower limits, which could be related to the
very rapid calcium deposition in bone mid-gestation. Pre-
term infants are prone to hypercalcaemia in the neonatal
intensive care unit, which can be seen secondary to
Table 4 Estimates from the multiple regression models and magnitude of influential variables in the multivariable
models
Analyte Variable Coefficient Standard Error p - value % mean % SD
Phosphate
(mg/dl)
Gestational Age (weeks) -0.057 0.01 < 0.001
Twin -0.10 0.09 0.28 -1.6 -11.3
Triplet -0.51 0.15 0.001 -8.3 -57.6
PIH -0.29 0.11 0.009 -4.7 -32.7
Intercept 8.07 0.33 < 0.001
Calcium Gestational Age (weeks) 0.054 0.01 < 0.001
(mg/dl) Twin -0.23 0.01 0.023 -2.2 -22.8
Triplet -0.40 0.17 0.017 -3.9 -39.6
SGA -0.33 0.13 0.012 -3.2 -32.7
PIH -0.38 0.11 0.001 -3.7 -37.6
Intercept 8.76 0.36 < 0.001
Albumin Gestational Age (weeks) 0.023 0.01 0.029
Adjusted SGA -0.30 0.11 0.009 -2.7 -32.4
Calcium PIH -0.38 0.10 < 0.001 -3.5 -41.1
(mg/dl) Caesarian delivery -0.28 0.09 0.001 -2.6 -30.3
Intercept 10.41 0.36 < 0.001
Magnesium Gestational Age (weeks) -0.007 0.002 0.006
(mg/dl) Twin -0.069 0.025 0.006 -3.7 -31.9
Triplet 0.023 0.042 0.58 1.2 10.6
Intercept 2.1 0.08 < 0.001
Alkaline Gestational Age (weeks) -3.69 0.74 < 0.001
Phosphatase Intercept 299 25 < 0.001
(units/L)
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blood serum calcium up to 12.4 mg/dl (3.1 mmol/L) is
acceptable given these reference intervals.
Serum calcium and phosphate were influenced by multi-
ple births; phosphate was significantly lower for triplets
while cord blood serum calcium was significantly lower
for twins. These effects were likely due to limited placental
supply due to limited nutrient supply to the multiple
fetuses.
In comparison to previous reports, our values for cord
blood serum phosphate were almost identical to four
other studies [7,8,12,13], but were lower than the small
study from Japan [9]. Our values for cord blood serum
calcium were similar to another cord blood report [7],
and slightly higher than five other studies [8,9,11-13].
Our magnesium values were slightly lower than one
study [8], and higher than another [13]. Compared to our
ALP values, fetal levels have been reported as similar [11]
or much higher [10,12].
Some previous work regarding analyte relationships
with gestational age agrees with our findings while some
others do not. Moniz et al also noted an increase in cord
blood serum calcium with increasing gestational age
among the foetuses assessed using fetoscopy [11]. Seki et
al [9] reported a more dramatic negative relationship
between phosphate and gestational age. In terms of ALP,
other researchers [10,12] also observed decreases in ALP
with gestational age among the preterm fetuses.
Although most literature regarding phosphate for pre-
term infants emphasizes phosphate’s role in bone minera-
lization, phosphate also has roles in glucose metabolism.
Serum phosphate decreases in response to infused glucose
in adults, [24], presumably due to it entering cells in
response to insulin secretion. Further, low cord blood
serum phosphate may limit clinical stability since it is
required for glucose tolerance, tissue sensitivity to insulin
[25], as well as glucose-induced insulin secretion [26].
Conclusions
Cord blood bone mineral levels (cord blood serum cal-
cium, phosphate, and magnesium) and related laboratory
tests (albumin-adjusted calcium and alkaline phospha-
tase) were related to gestational age, the several of them
(calcium and phosphate) were also related to pregnancy-
induced hypertension, size for gestational age and multi-
ple birth. Therefore, it seems desirable to consider these
variables and how they co-vary with gestational age in
the development of reference intervals. Further study is
required to define the optimal cord blood serum levels of
these analytes for preterm infants.
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